KIM PETER S — SEC Form 4 filings
SEC reporting owner CIK 1181180. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-21 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 13 legs across 7 filings — 95,368 shares, $1,373,622 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: purchase of 25,000 shares @ $14.68 ($367,010) in Entrada Therapeutics, Inc., filed 2025-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | Director | 11 | 13 legs · 95,368 sh · $1,373,622 | — | 5 |
Form 4 filings — KIM PETER S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4/A | Entrada Therapeutics, Inc. (TRDA) | Purchase (P): 25,000 @ $14.68 · Purchase (P): 25,000 @ $14.59 | EDGAR |
| 2025-06-12 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Entrada Therapeutics, Inc. (TRDA) | Option exercise (M): 11,918 @ $6.06 · Option exercise (M): 11,918 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | Entrada Therapeutics, Inc. (TRDA) | Purchase (P): 25,000 @ $14.59 | EDGAR |
| 2024-05-10 | 4 | Entrada Therapeutics, Inc. (TRDA) | Purchase (P): 2,276 @ $14.04 · Purchase (P): 2,200 @ $14.25 | EDGAR |
| 2024-04-10 | 4 | Entrada Therapeutics, Inc. (TRDA) | Purchase (P): 2,600 @ $13.57 | EDGAR |
| 2024-04-01 | 4 | Entrada Therapeutics, Inc. (TRDA) | Purchase (P): 1,512 @ $13.75 | EDGAR |
| 2024-03-26 | 4 | Entrada Therapeutics, Inc. (TRDA) | Purchase (P): 3,118 @ $13.76 · Purchase (P): 3,180 @ $13.36 · Purchase (P): 2,750 @ $13.64 | EDGAR |
| 2024-03-21 | 4 | Entrada Therapeutics, Inc. (TRDA) | Purchase (P): 900 @ $12.66 · Purchase (P): 1,128 @ $12.66 · Purchase (P): 704 @ $13.24 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1181180 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →